a public good project by the
Synthesis
Company
of California

© 2026

Elena Zotova | doi.page

0 works0 citations0 h-index

Elena Zotova

Université Pierre Mendès France(FR)Population Health Research Institute(CA)

Publications by Year

Research Areas

Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, Intracerebral and Subarachnoid Hemorrhage Research, Advanced Glycation End Products research, Glutathione Transferases and Polymorphisms

Most-Cited Works

→ Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors(2019)929 cited
→ Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors(2016)781 cited
→ Polymorphisms in the Mn-SOD and EC-SOD Genes and Their Relationship to Diabetic Neuropathy in Type 1 Diabetes Mellitus(2001)68 cited
→ Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy(2021)64 cited
→ Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor–Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care(2021)63 cited
→ Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study(2003)45 cited

→ Association of Polymorphic Markers of the Antioxidant Enzyme Genes with Diabetic Polyneuropathy in Type 1 Diabetes Mellitus(2004)

24 cited

→ Association of the SOD2 Ala(–9)Val and SOD3 Arg213Gly Polymorphisms with Diabetic Polyneuropathy in Diabetes Mellitus Type 1(2003)22 cited

→ The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the −129A allele in women(2009)12 cited

→ Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in type 1 diabetes mellitus(2005)7 cited